Frontiers DXA-Derived Adiposity and Lean Indices for Management of Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and Reporting Tips

Frontiers  DXA-Derived Adiposity and Lean Indices for Management of  Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and  Reporting Tips

Frontiers DXA-Derived Adiposity and Lean Indices for Management of Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and Reporting Tips

Frontiers  DXA-Derived Adiposity and Lean Indices for Management of  Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and  Reporting Tips

Body Fat Distribution and Risk of Cardiovascular Disease

Frontiers  DXA-Derived Adiposity and Lean Indices for Management of  Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and  Reporting Tips

Association of machine learning-derived measures of body fat distribution with cardiometabolic diseases in >40,000 individuals

Frontiers  DXA-Derived Adiposity and Lean Indices for Management of  Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and  Reporting Tips

State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions. - Abstract - Europe PMC

Frontiers  DXA-Derived Adiposity and Lean Indices for Management of  Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and  Reporting Tips

Contribution of individual and cumulative frailty-related health deficits on cardiac rehabilitation completion, BMC Geriatrics

Frontiers  DXA-Derived Adiposity and Lean Indices for Management of  Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and  Reporting Tips

Piera Lalli's research works Università degli Studi di Torino, Turin (UNITO) and other places

Frontiers  DXA-Derived Adiposity and Lean Indices for Management of  Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and  Reporting Tips

Frontiers DXA-Derived Adiposity and Lean Indices for Management of Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and Reporting Tips, m 40 / f 39.5 o que significa

Frontiers  DXA-Derived Adiposity and Lean Indices for Management of  Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and  Reporting Tips

Frontiers DXA-Derived Adiposity and Lean Indices for Management of Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and Reporting Tips, m 40 / f 39.5 o que significa

Frontiers  DXA-Derived Adiposity and Lean Indices for Management of  Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and  Reporting Tips

Frontiers DXA-Derived Adiposity and Lean Indices for Management of Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and Reporting Tips, m 40 / f 39.5 o que significa

Frontiers  DXA-Derived Adiposity and Lean Indices for Management of  Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and  Reporting Tips

Body Fat Distribution and Risk of Cardiovascular Disease

Frontiers  DXA-Derived Adiposity and Lean Indices for Management of  Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and  Reporting Tips

Anthropometric parameters‐derived estimation of muscle mass predicts all‐cause mortality in heart failure patients - Katano - 2022 - ESC Heart Failure - Wiley Online Library

Frontiers  DXA-Derived Adiposity and Lean Indices for Management of  Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and  Reporting Tips

Association of change in fat and lean mass with incident cardiovascular events for women in midlife and beyond: A prospective study using dual-energy x-ray absorptiometry (DXA) - Maturitas

Frontiers  DXA-Derived Adiposity and Lean Indices for Management of  Cardiometabolic and Musculoskeletal Frailty: Data Interpretation Tricks and  Reporting Tips

Frontiers Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial